Skip to main content
FDA to review dupilumab for treating chronic spontaneous urticaria
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
FDA to review dupilumab for treating chronic spontaneous urticaria
User login
Username
Password
Reset your password
Concept
Lead
score
Urticaria and Angioedema
1
1
Urticaria
0
0.97
Pruritus
0
0.43
Adolescent Medicine
0
0.32
Asthma
0
0.28
Biologic Therapy
0
0.24
Antihistamine
0
0.22
Dermatitis
0
0.21
Immunoglobulin E (IgE) Antibody
0
0.15
Airway
0
0.11
Allergy
0
0.11
Angioedema
0
0.11
Angioneurotic Edema
0
0.11
Atopic Dermatitis
0
0.11
Face
0
0.11
Hand
0
0.11
Immunoglobulin E (IgE)
0
0.11
Immunology
0
0.11
Interleukin
0
0.11
Monoclonal Antibody
0
0.11
Pedal
0
0.11
Specialty
Lead
score
Dermatology
1
1
Family Medicine/Primary Care
0
0.8
Pediatrics
0
0.7
Pharmacist
0
0.6
Internal Medicine
0
0.9
Edit Tags